Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
Phase 2
Terminated
- Conditions
- Rheumatoid Arthritis (RA)
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2009-03-13
- Lead Sponsor
- Dainippon Sumitomo Pharma Europe LTd.
- Target Recruit Count
- 312
- Registration Number
- NCT00296257
© Copyright 2025. All Rights Reserved by MedPath